Drugs News and Research

RSS

New research project to make anti-malarial drugs more affordable in Third World countries

Dr Geoff Brown, from the University of Reading's Department of Chemistry, is beginning a £400,000 project that could prove vital for the developing world in its ongoing fight against malaria. His research aims to make anti-malarial drugs more affordable in Third World countries where more than 1.5 million people die of the disease every year.

24 Apr 2010

Myths and facts about pediatric cancer

"Your child has cancer." They are words every parent can't imagine hearing.

24 Apr 2010

RXi Pharmaceuticals to present data on rxRNA therapeutic platform development at upcoming conferences

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.

24 Apr 2010

Senate Budget Committee approves FY 2011 budget resolution with cuts to foreign aid

The Senate Budget Committee has approved a budget resolution that adheres to President Barack Obama's "proposal to freeze non-defense spending, then goes a bit further" with cuts to "the State Department and other international programs," the Washington Post reports (Montgomery, 4/23).

24 Apr 2010

Federal officials confirm states may lose some Medicaid drug rebate money

"The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul," Kaiser Health News reports.

24 Apr 2010

Recent releases in Global Health

"What is still needed [to fight malaria] is the only tool that has ever truly conquered any infectious disease: an effective and affordable vaccine. And here, the global malaria community has been too complacent," a Lancet editorial asserts in an article highlighting achievements and drawbacks in attempting to provide universal access to malaria prevention and treatment.

24 Apr 2010

PMI releases 6-year malaria strategy

The U.S. government Thursday released a six-year strategy to address malaria globally, Reuters reports (Fox, 4/22). The plan was issued through the President's Malaria Initiative (PMI) in conjunction with World Malaria Day, April 25, and is a "core component of President [Barack] Obama's Global Health Initiative," according to a USAID press release (4/22).

24 Apr 2010

Rapid diagnostic tests for malaria

A new evaluation of malaria rapid diagnostic tests will help health workers quickly identify which patients have the disease and need immediate treatment, putting into action recent World Health Organization recommendations to confirm diagnosis of malaria before treatment.

24 Apr 2010

State of California adds Distracted Driving as new area for concentrated effort to SHSP

Driver distractions have joined alcohol and speeding as leading factors in fatal and serious injury crashes. The National Safety Council estimates that up to 25 percent of all crashes in 2008 involved talking on cell phones or texting. To combat this growing threat on our roadways, the State of California has added Distracted Driving as the first new area for concentrated effort to the Strategic Highway Safety Plan.

23 Apr 2010

MicroStockProfit.com releases investment report on ANX

MicroStockProfit.com announces an investment report featuring ADVENTRX Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

23 Apr 2010

GIS scientists' zebrafish model may aid drug development for PD

Scientists at the Genome Institute of Singapore, a biomedical research institute of the Agency for Science, Technology and Research, have recently developed a zebrafish model for Parkinson's disease that can be used for understanding the mechanism underlying its development. The knowledge gained will be helpful for future screening of new drugs to treat Parkinson's disease.

23 Apr 2010

GenVec's 2009 revenues down 8%: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring GenVec Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

23 Apr 2010

EpiCept invites stockholders to attend Annual Meeting

With this notice, stockholders of EpiCept Corporation are invited to the Annual Meeting of Stockholders on June 3, 2010, at 10:00 a.m. Eastern time at the Dolce/IBM Palisades Executive Conference Center, 334 Route 9W, Palisades, New York 10964.

23 Apr 2010

European Patent Office intends to grant patent for Intezyne's IVECT Method

Intezyne today announced it has received notification the European Patent Office intends to grant a patent covering a key element of Intezyne's breakthrough drug delivery technology, the IVECT Method. At the core of this technology is the IVECT micelle, a proprietary, polymeric nanoparticle designed to encapsulate and deliver best-in-class therapeutics, while limiting exposure to healthy tissues.

23 Apr 2010

Report on Canadian spending trends in prescribed and non-prescribed drugs

Total drug spending in Canada is estimated to have reached $30.0 billion in 2009, about $1.5 billion more than in 2008, according to a new report released today by the Canadian Institute for Health Information (CIHI). This represents an estimated increase of 5.1%, the lowest annual growth rate observed in more than a decade.

23 Apr 2010

Compugen announces development of PPI Blockers Discovery Platform

Compugen Ltd. announced today the development of its Protein-Protein Interaction Blockers (PPI Blockers) Discovery Platform, designed for the prediction of peptides to block disease associated protein-protein interactions. In a pilot validation run, predicted peptides showed positive results for drug targets in two cancer related pathways of interest to the industry.

23 Apr 2010

Researchers take major step to predict adverse drug reactions using genetic information

In a new study, researchers at Mount Sinai School of Medicine have taken a major step toward the ability to predict adverse drug reactions, using genetic, cellular, and clinical information to learn why some medicines cause heart arrhythmias in patients. Published in the April 20 issue of the journal Science Signaling, the new framework described in the study could potentially be applied to the study of medications that treat other diseases and disorders such as epilepsy and autism.

23 Apr 2010

Opinions: New U.S.-backed global food, agriculture program; Foreign aid to Africa; Medicines in Africa

In a Wall Street Journal opinion piece, U.S. Secretary of the Treasury Timothy Geithner and Bill Gates, co-chair of the Bill & Melinda Gates Foundation, announce the launch of the Global Agriculture and Food Security Program, a fund "to help the world's poorest farmers grow more food and earn more than they do now so they can lift themselves out of hunger and poverty."

23 Apr 2010

New ways for earlier diagnosis of osteoarthritis

Researchers at King's College London's Department of Twin Research and Genetic Epidemiology, based at St Thomas' Hospital have discovered new ways of measuring biological markers in the blood which could be used to diagnose osteoarthritis earlier.

23 Apr 2010

New multi-faceted treatment program for young adults addicted to opioid drugs

A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders.

23 Apr 2010